Company Filing History:
3 out of 1,178 
2 out of 134 
Years Active: 2007-2019
Title: Innovator Profile: Mark E. Adams
Introduction: Mark E. Adams, an accomplished inventor based in San Diego, CA, has made significant contributions to the field of pharmaceuticals. With a notable track record of five patents, Adams has focused his innovative efforts on developing compounds that modulate GPR6, which is linked to various medical conditions.
Latest Patents: Among his latest patents, the invention titled “Pyrazines as modulators of GPR6” stands out. This invention provides compounds of a specific formula that are particularly useful as modulators of GPR6. The patent outlines pharmaceutical compositions aimed at treating conditions associated with GPR6 and details the processes for synthesizing these compounds and their intermediates.
Career Highlights: Throughout his career, Mark E. Adams has worked with prominent pharmaceutical companies, including Takeda Pharmaceutical Company Limited and Ligand Pharmaceuticals, Inc. His expertise and innovative approach in these organizations have led to advancements in drug development and therapeutic applications.
Collaborations: Adams has collaborated with notable professionals in the field, such as Robert Higuchi and Lin Zhi. His teamwork and collective expertise have propelled the progress of various projects, leading to successful inventions and beneficial pharmaceutical advancements.
Conclusion: Mark E. Adams exemplifies the spirit of innovation within the pharmaceutical industry. His dedication to developing effective treatments through the modulation of GPR6 has opened new pathways for addressing medical challenges. With a solid foundation of patents and collaborations, Adams continues to be a significant figure in the field of pharmaceuticals.